140 Participants Needed

Lifestyle Interventions for Mild Cognitive Impairment

BJ
ND
Overseen ByNicole D Anderson, PhD
Age: 65+
Sex: Any
Trial Phase: Academic
Sponsor: University of Waterloo

Trial Summary

What is the purpose of this trial?

The objective of this study is to investigate the feasibility of a virtually-delivered 6-month exercise and nutrition intervention in older adults with executive subjective cognitive decline (SCD). Feasibility will be determined by recruitment, retention, and adherence rates. Preliminary changes in cognition, physical function, and quality of life will be assessed as secondary outcomes. The study will recruit 140 participants aged 65 to 80 who report they feel that their memory or other thinking abilities are declining. Participants will be randomized into one of four study arms receiving different combinations of healthy lifestyle interventions. Assessments will be conducted virtually at baseline, post-intervention (6 months), and follow-up (12 months). All intervention sessions and assessment visits will be conducted online using the Zoom Healthcare platform and participants will log on using their own devices from home.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It might be best to discuss this with the study team or your doctor.

What data supports the effectiveness of the treatment LEAD 2.0 for mild cognitive impairment?

Research shows that combining physical exercise and diet can help improve cognitive function in people with mild cognitive impairment, potentially slowing the progression to dementia. Additionally, mind-body exercises and lifestyle changes have been found to enhance cognitive performance in middle-aged and older adults with mild cognitive impairment.12345

Is the LEAD 2.0 intervention generally safe for humans?

Lifestyle clinical trials, including those involving exercise and diet, are generally safe with no significant increase in serious adverse events compared to control groups. However, some trials involving diet/supplement and multi-modal interventions showed an increased risk of adverse events, so these results should be considered carefully.16789

How is the LEAD 2.0 treatment different from other treatments for mild cognitive impairment?

The LEAD 2.0 treatment is unique because it focuses on lifestyle changes, combining exercise and diet, rather than relying on medication. This approach is designed to improve cognitive function and brain health through non-pharmacological means, which may be more accessible and sustainable for some patients.17101112

Research Team

LM

Laura Middleton, PhD

Principal Investigator

University of Waterloo

Eligibility Criteria

The LEAD 2.0 trial is for adults aged 65-80 in Quebec, Ontario, Manitoba, and Saskatchewan who feel their cognitive abilities are declining but do not have dementia or other severe brain conditions. They should be physically inactive (<75min/week of exercise), have a poor diet, and be able to use a computer with internet for remote participation.

Inclusion Criteria

I am between 65 and 80 years old.
Reside in Quebec, Ontario, Manitoba, or Saskatchewan
Low physical activity levels (<75 minutes/week of moderate/vigorous physical activity)
See 8 more

Exclusion Criteria

I have been diagnosed with a chronic brain condition.
Sensory impairments that hinder participation in the intervention or assessments
Major psychiatric disorder
See 3 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks
2 visits (virtual)

Treatment

Participants engage in a 6-month virtual exercise and nutrition intervention

6 months
Weekly virtual sessions

Follow-up

Participants are monitored for changes in cognition, physical function, and quality of life

6 months
2 visits (virtual)

Treatment Details

Interventions

  • LEAD 2.0
Trial OverviewThis study tests if older adults can stick to a 6-month virtual program focused on exercise and nutrition to improve cognition, physical function, and quality of life. Participants will join one of four groups receiving different combinations of exercises (EX), stretching (STRETCH), dietary changes (DIET), or educational sessions (ED).
Participant Groups
4Treatment groups
Experimental Treatment
Active Control
Placebo Group
Group I: EX + DIETExperimental Treatment2 Interventions
Participants will engage in 3 sessions per week (2 EX, 1 DIET, totaling 4 hours per week), consisting of two virtual group sessions (totaling 3 hours) and one independent session (1 hour) (Table 1). Virtual group sessions will occur in groups of 6-8 participants using the Zoom Healthcare platform (on a computer or tablet).
Group II: EX + EDActive Control2 Interventions
Participants will engage in 3 sessions per week (2 EX, 1 ED, totaling 4 hours per week), consisting of two virtual group sessions (totaling 3 hours) and one independent session (1 hour) (Table 1). Virtual group sessions will occur in groups of 6-8 participants using the Zoom Healthcare platform (on a computer or tablet).
Group III: STRETCH + DIETActive Control2 Interventions
Participants will engage in 3 sessions per week (2 STRETCH, 1 DIET, totaling 4 hours per week), consisting of two virtual group sessions (totaling 3 hours) and one independent session (1 hour) (Table 1). Virtual group sessions will occur in groups of 6-8 participants using the Zoom Healthcare platform (on a computer or tablet).
Group IV: STRETCH + EDPlacebo Group2 Interventions
Participants will engage in 3 sessions per week (2 STRETCH, 1 ED) totaling 4 hours per week), consisting of two virtual group sessions (totaling 3 hours) and one independent session (1 hour) (Table 1). Virtual group sessions will occur in groups of 6-8 participants using the Zoom Healthcare platform (on a computer or tablet)

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Waterloo

Lead Sponsor

Trials
132
Recruited
221,000+

Baycrest

Collaborator

Trials
46
Recruited
6,900+

University of Ottawa

Collaborator

Trials
231
Recruited
267,000+

Université de Montréal

Collaborator

Trials
223
Recruited
104,000+

Findings from Research

Recruitment for a one-year exercise trial in individuals with mild cognitive impairment (MCI) was significantly more successful at a non-medical sport university compared to traditional memory clinics, highlighting the importance of the environment in attracting participants.
The study suggests that non-medical settings and community-based physical activity programs may enhance recruitment and retention in prevention trials for MCI, which is crucial for the success of such interventions.
Real World Recruiting of Older Subjects with Mild Cognitive Impairment for Exercise Trials: Community Readiness is Pivotal.Sanders, ML., Stuckenschneider, T., Devenney, KE., et al.[2022]
Scheduled moderate to high-intensity physical exercise, performed 3 to 5 days a week, combined with dietary patterns like the Mediterranean or DASH diet, significantly improves cognitive function in individuals over 45 with mild cognitive impairment (MCI).
Combining physical exercise with cognitive stimulation exercises enhances the benefits, leading to better functionality and quality of life for those with MCI, although the variability in study designs complicates specific recommendations.
[Effect of physical exercise and diet based interventions on the evolution of cognitive impairment to dementia in subjects older than 45 years. A systematic review.]Ballarín-Naya, L., Malo, S., Moreno-Franco, B.[2023]
A systematic review of 27 studies involving 2565 participants with mild cognitive impairment (MCI) found that physical and mental exercises, such as Tai Chi and dance, significantly improved cognitive performance, as indicated by various cognitive assessment scores.
These exercises not only enhanced cognitive abilities but also positively affected biomarkers, increasing levels of the beneficial αβ1-42 protein and decreasing Tau protein levels, suggesting a potential mechanism for their efficacy in managing MCI.
Effects of mind-body exercise on cognitive performance in middle-aged and older adults with mild cognitive impairment: A meta-analysis study.Cai, H., Zhang, K., Wang, M., et al.[2023]

References

Real World Recruiting of Older Subjects with Mild Cognitive Impairment for Exercise Trials: Community Readiness is Pivotal. [2022]
[Effect of physical exercise and diet based interventions on the evolution of cognitive impairment to dementia in subjects older than 45 years. A systematic review.] [2023]
Effects of mind-body exercise on cognitive performance in middle-aged and older adults with mild cognitive impairment: A meta-analysis study. [2023]
A pilot feasibility randomized controlled trial on combining mind-body physical exercise, cognitive training, and nurse-led risk factor modification to reduce cognitive decline among older adults with mild cognitive impairment in primary care. [2022]
Lifestyle Risk Factors and Cognitive Outcomes from the Multidomain Dementia Risk Reduction Randomized Controlled Trial, Body Brain Life for Cognitive Decline (BBL-CD). [2021]
A Retrospective Analysis of Serious Adverse Events and Deaths in US-Based Lifestyle Clinical Trials for Cognitive Health. [2023]
Randomized trial on the effects of a combined physical/cognitive training in aged MCI subjects: the Train the Brain study. [2018]
Feasibility and acceptability of a multi-domain intervention to increase Mediterranean diet adherence and physical activity in older UK adults at risk of dementia: protocol for the MedEx-UK randomised controlled trial. [2022]
Adherence to exercise interventions in older people with mild cognitive impairment and dementia: A systematic review and meta-analysis. [2021]
10.United Statespubmed.ncbi.nlm.nih.gov
Association of Modifiable Lifestyle Factors With Cortical Amyloid Burden and Cerebral Glucose Metabolism in Older Adults With Mild Cognitive Impairment. [2020]
11.United Statespubmed.ncbi.nlm.nih.gov
Exercise training for cognitive and physical function in patients with mild cognitive impairment: A PRISMA-compliant systematic review and meta-analysis. [2022]
NeuroExercise: The Effect of a 12-Month Exercise Intervention on Cognition in Mild Cognitive Impairment-A Multicenter Randomized Controlled Trial. [2021]